These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 31954439)

  • 1. Global prevalence of hepatitis C virus in children in 2018: a modelling study.
    Schmelzer J; Dugan E; Blach S; Coleman S; Cai Z; DePaola M; Estes C; Gamkrelidze I; Jerabek K; Ma S; Montoya S; Razavi-Shearer D; Razavi-Shearer K; Robbins-Scott S; Razavi H; El Sayed MH
    Lancet Gastroenterol Hepatol; 2020 Apr; 5(4):374-392. PubMed ID: 31954439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global prevalence of hepatitis C virus in women of childbearing age in 2019: a modelling study.
    Dugan E; Blach S; Biondi M; Cai Z; DePaola M; Estes C; Feld J; Gamkrelidze I; Kottilil S; Ma S; Mathur P; Montoya S; Razavi-Shearer D; Razavi-Shearer K; Robbins-Scott S; Schmelzer J; Razavi H
    Lancet Gastroenterol Hepatol; 2021 Mar; 6(3):169-184. PubMed ID: 33515496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study.
    Polaris Observatory HCV Collaborators
    Lancet Gastroenterol Hepatol; 2022 May; 7(5):396-415. PubMed ID: 35180382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating paediatric hepatitis C in the era of direct-acting antiviral agents.
    Alqahtani SA; Colombo MG
    Liver Int; 2021 Jun; 41(6):1189-1200. PubMed ID: 33533543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study.
    European Union HCV Collaborators
    Lancet Gastroenterol Hepatol; 2017 May; 2(5):325-336. PubMed ID: 28397696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study.
    Polaris Observatory HCV Collaborators
    Lancet Gastroenterol Hepatol; 2017 Mar; 2(3):161-176. PubMed ID: 28404132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic overview of hepatitis C infection in the Middle East and North Africa.
    Chaabna K; Cheema S; Abraham A; Alrouh H; Lowenfels AB; Maisonneuve P; Mamtani R
    World J Gastroenterol; 2018 Jul; 24(27):3038-3054. PubMed ID: 30038471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between rapid utilisation of direct hepatitis C antivirals and decline in the prevalence of viremia among people who inject drugs in Australia.
    Iversen J; Dore GJ; Catlett B; Cunningham P; Grebely J; Maher L
    J Hepatol; 2019 Jan; 70(1):33-39. PubMed ID: 30367897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burden of pediatric hepatitis C.
    El-Shabrawi MH; Kamal NM
    World J Gastroenterol; 2013 Nov; 19(44):7880-8. PubMed ID: 24307782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimated prevalence of undiagnosed HCV infected individuals in Italy: A mathematical model by route of transmission and fibrosis progression.
    Kondili LA; Andreoni M; Alberti A; Lobello S; Babudieri S; Roscini AS; Merolla R; Marrocco W; Craxì A
    Epidemics; 2021 Mar; 34():100442. PubMed ID: 33607538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling the potential prevention benefits of a treat-all hepatitis C treatment strategy at global, regional and country levels: A modelling study.
    Trickey A; Fraser H; Lim AG; Walker JG; Peacock A; Colledge S; Leung J; Grebely J; Larney S; Martin NK; Degenhardt L; Hickman M; May MT; Vickerman P
    J Viral Hepat; 2019 Dec; 26(12):1388-1403. PubMed ID: 31392812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes.
    Petruzziello A; Marigliano S; Loquercio G; Cozzolino A; Cacciapuoti C
    World J Gastroenterol; 2016 Sep; 22(34):7824-40. PubMed ID: 27678366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 3.
    Liakina V; Hamid S; Tanaka J; Olafsson S; Sharara AI; Alavian SM; Gheorghe L; El Hassan ES; Abaalkhail F; Abbas Z; Abdou A; Abourached A; Al Braiki F; Al Hosani F; Al Jaberi K; Al Khatry M; Al Mulla MA; Al Quraishi H; Al Rifai A; Al Serkal Y; Alam A; Alashgar HI; Alawadhi S; Al-Dabal L; Aldins P; Alfaleh FZ; Alghamdi AS; Al-Hakeem R; Aljumah AA; Almessabi A; Alqutub AN; Alswat KA; Altraif I; Alzaabi M; Andrea N; Assiri AM; Babatin MA; Baqir A; Barakat MT; Bergmann OM; Bizri AR; Blach S; Chaudhry A; Choi MS; Diab T; Djauzi S; El Khoury S; Estes C; Fakhry S; Farooqi JI; Fridjonsdottir H; Gani RA; Ghafoor Khan A; Goldis A; Gottfredsson M; Gregorcic S; Hajarizadeh B; Han KH; Hasan I; Hashim A; Horvath G; Hunyady B; Husni R; Jafri W; Jeruma A; Jonasson JG; Karlsdottir B; Kim DY; Kim YS; Koutoubi Z; Lesmana LA; Lim YS; Löve A; Maimets M; Makara M; Malekzadeh R; Matičič M; Memon MS; Merat S; Mokhbat JE; Mourad FH; Muljono DH; Nawaz A; Nugrahini N; Priohutomo S; Qureshi H; Rassam P; Razavi H; Razavi-Shearer D; Razavi-Shearer K; Rozentale B; Sadik M; Saeed K; Salamat A; Salupere R; Sanai FM; Sanityoso Sulaiman A; Sayegh RA; Schmelzer JD; Sibley A; Siddiq M; Siddiqui AM; Sigmundsdottir G; Sigurdardottir B; Speiciene D; Sulaiman A; Sultan MA; Taha M; Tarifi H; Tayyab G; Tolmane I; Ud Din M; Umar M; Valantinas J; Videčnik-Zorman J; Yaghi C; Yunihastuti E; Yusuf MA; Zuberi BF; Gunter J
    J Viral Hepat; 2015 Dec; 22 Suppl 4():4-20. PubMed ID: 26513445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Birth cohort distribution and screening for viraemic hepatitis C virus infections in Switzerland.
    Bruggmann P; Negro F; Bihl F; Blach S; Lavanchy D; Müllhaupt B; Razavi H; Semela D
    Swiss Med Wkly; 2015; 145():w14221. PubMed ID: 26715488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of Hepatitis C in Children Without Identifiable Risk-Factors: A Systematic Review and Meta-Analysis.
    Melikoki V; Kourlaba G; Kanavaki I; Fessatou S; Papaevangelou V
    J Pediatr Gastroenterol Nutr; 2021 Jun; 72(6):e140-e148. PubMed ID: 33633077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global epidemiology and genotype distribution of the hepatitis C virus infection.
    Gower E; Estes C; Blach S; Razavi-Shearer K; Razavi H
    J Hepatol; 2014 Nov; 61(1 Suppl):S45-57. PubMed ID: 25086286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence.
    Mohd Hanafiah K; Groeger J; Flaxman AD; Wiersma ST
    Hepatology; 2013 Apr; 57(4):1333-42. PubMed ID: 23172780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global burden of disease (GBD) for hepatitis C.
    Global Burden Of Hepatitis C Working Group
    J Clin Pharmacol; 2004 Jan; 44(1):20-9. PubMed ID: 14681338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C viraemic and seroprevalence and risk factors for positivity in Northwest Cambodia: a household cross-sectional serosurvey.
    Lynch E; Falq G; Sun C; Bunchhoeung PDT; Huerga H; Loarec A; Dousset JP; Marquardt T; Paih ML; Maman D
    BMC Infect Dis; 2021 Feb; 21(1):223. PubMed ID: 33637051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015.
    GBD 2015 Tobacco Collaborators
    Lancet; 2017 May; 389(10082):1885-1906. PubMed ID: 28390697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.